PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XDN0.L vs. PPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


XDN0.LPPH
YTD Return-0.39%13.38%
1Y Return8.62%21.87%
3Y Return (Ann)1.57%8.06%
5Y Return (Ann)10.54%10.76%
10Y Return (Ann)12.16%5.55%
Sharpe Ratio0.651.82
Sortino Ratio1.032.54
Omega Ratio1.121.32
Calmar Ratio0.731.95
Martin Ratio2.087.07
Ulcer Index4.14%2.74%
Daily Std Dev13.30%10.67%
Max Drawdown-24.85%-46.49%
Current Drawdown-11.76%-8.13%

Correlation

-0.50.00.51.00.4

The correlation between XDN0.L and PPH is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

XDN0.L vs. PPH - Performance Comparison

In the year-to-date period, XDN0.L achieves a -0.39% return, which is significantly lower than PPH's 13.38% return. Over the past 10 years, XDN0.L has outperformed PPH with an annualized return of 12.16%, while PPH has yielded a comparatively lower 5.55% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-6.29%
2.75%
XDN0.L
PPH

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XDN0.L vs. PPH - Expense Ratio Comparison

XDN0.L has a 0.30% expense ratio, which is lower than PPH's 0.36% expense ratio.


PPH
VanEck Vectors Pharmaceutical ETF
Expense ratio chart for PPH: current value at 0.36% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.36%
Expense ratio chart for XDN0.L: current value at 0.30% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.30%

Risk-Adjusted Performance

XDN0.L vs. PPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Nordic UCITS ETF 1D (XDN0.L) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XDN0.L
Sharpe ratio
The chart of Sharpe ratio for XDN0.L, currently valued at 0.83, compared to the broader market-2.000.002.004.000.83
Sortino ratio
The chart of Sortino ratio for XDN0.L, currently valued at 1.32, compared to the broader market-2.000.002.004.006.008.0010.0012.001.32
Omega ratio
The chart of Omega ratio for XDN0.L, currently valued at 1.15, compared to the broader market1.001.502.002.503.001.15
Calmar ratio
The chart of Calmar ratio for XDN0.L, currently valued at 1.12, compared to the broader market0.005.0010.0015.001.12
Martin ratio
The chart of Martin ratio for XDN0.L, currently valued at 3.44, compared to the broader market0.0020.0040.0060.0080.00100.003.44
PPH
Sharpe ratio
The chart of Sharpe ratio for PPH, currently valued at 1.97, compared to the broader market-2.000.002.004.001.97
Sortino ratio
The chart of Sortino ratio for PPH, currently valued at 2.79, compared to the broader market-2.000.002.004.006.008.0010.0012.002.79
Omega ratio
The chart of Omega ratio for PPH, currently valued at 1.35, compared to the broader market1.001.502.002.503.001.35
Calmar ratio
The chart of Calmar ratio for PPH, currently valued at 2.06, compared to the broader market0.005.0010.0015.002.06
Martin ratio
The chart of Martin ratio for PPH, currently valued at 7.47, compared to the broader market0.0020.0040.0060.0080.00100.007.47

XDN0.L vs. PPH - Sharpe Ratio Comparison

The current XDN0.L Sharpe Ratio is 0.65, which is lower than the PPH Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of XDN0.L and PPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
0.83
1.97
XDN0.L
PPH

Dividends

XDN0.L vs. PPH - Dividend Comparison

XDN0.L's dividend yield for the trailing twelve months is around 2.68%, more than PPH's 1.76% yield.


TTM20232022202120202019201820172016201520142013
XDN0.L
Xtrackers MSCI Nordic UCITS ETF 1D
2.68%2.51%4.53%1.09%4.82%4.18%1.05%2.34%1.52%0.00%3.16%0.00%
PPH
VanEck Vectors Pharmaceutical ETF
1.76%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%1.71%2.03%

Drawdowns

XDN0.L vs. PPH - Drawdown Comparison

The maximum XDN0.L drawdown since its inception was -24.85%, smaller than the maximum PPH drawdown of -46.49%. Use the drawdown chart below to compare losses from any high point for XDN0.L and PPH. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-10.85%
-8.13%
XDN0.L
PPH

Volatility

XDN0.L vs. PPH - Volatility Comparison

Xtrackers MSCI Nordic UCITS ETF 1D (XDN0.L) has a higher volatility of 3.98% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 3.32%. This indicates that XDN0.L's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
3.98%
3.32%
XDN0.L
PPH